Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients. 1984

N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson

Lymphocyte proliferation (LP) by phytohemagglutinin (PHA) and two suppressor systems of mononuclear cells was investigated in 22 patients with Hodgkin's disease (HD) who were apparently cured at the time of study. The results were compared with those obtained in healthy controls and in a group of patients with inoperable carcinoma of the bronchus. The prostaglandin-related suppressor cell system ( PGSS ) was tested by adding 1 microgram/ml indomethacin to the mononuclear leukocyte cultures. The adherent cell suppressor system ( ACSS ) was tested by removal of the adherent cells on plastic petri dishes. The PGSS index of suppression was defined as the ratio of LP by PHA with indomethacin to LP without indomethacin. The ACSS index was defined as the ratio of the nonadherent cell LP to the total LP. The mean PGSS index in HD patients (1.1 +/- 0.25) was significantly higher (p less than 0.01) than in healthy controls (0.94 +/- 0.2). The ACSS index in HD patients (1.08 +/- 0.47) was also higher (p less than 0.02) than in controls. The LP by PHA value in HD patients (23,908 +/- 14,770 cpm) was significantly lower (p less than 0.001) than in controls (47,151 +/- 17,706 cpm). ACSS values in bronchogenic cancer patients were lower than in HD patients. The LP by PHA value was significantly lower in HD patients compared with bronchogenic carcinoma patients (p less than 0.02). HD patients who had a PGSS index of 1.3 or higher had a significantly lower LP value than those with a PGSS index lower than 1.3.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010835 Phytohemagglutinins Mucoproteins isolated from the kidney bean (Phaseolus vulgaris); some of them are mitogenic to lymphocytes, others agglutinate all or certain types of erythrocytes or lymphocytes. They are used mainly in the study of immune mechanisms and in cell culture. Kidney Bean Lectin,Kidney Bean Lectins,Lectins, Kidney Bean,Phaseolus vulgaris Lectin,Phaseolus vulgaris Lectins,Phytohemagglutinin,Hemagglutinins, Plant,Lectin, Kidney Bean,Lectin, Phaseolus vulgaris,Lectins, Phaseolus vulgaris,Plant Hemagglutinins
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma

Related Publications

N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
November 1977, The New England journal of medicine,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
May 1981, Blood,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
January 1981, Annales d'immunologie,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
June 1994, Journal of clinical pathology,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
January 2002, Bulletin du cancer,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
January 1981, International archives of allergy and applied immunology,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
May 1977, Scandinavian journal of haematology,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
April 1985, Cancer,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
August 1980, Clinical immunology and immunopathology,
N Haim, and A Meidav, and B Samuelly, and R Segal, and T Mekori, and E Robinson
January 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!